Pharmacological Treatment of Presbyopia

Status Recruiting

Clinical Trial Summary

In this clinical trial, a total of 75 presbyopic patients in the age range of 40 to 60 years old will be participated. The right eyes of 45 patients will be treated by Biocarpine® and they will be considered as the case group, their left eyes will be defined as the controls. In another case group, the right eyes of 30 patients will received Vuity® eye drops and their left eyes will be considered as controls.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05564832
Study type	Interventional
Source	Shahid Beheshti University of Medical Sciences
Contact
Status	Recruiting
Phase	Early Phase 1
Start date	August 1, 2022
Completion date	January 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06045299` - Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia	Phase 3
Completed	`NCT05359380` - The Impact of Light Conditions on the Efficacy of Multifocal Intraocular Lens Implantation in Activities of Daily Living
Recruiting	`NCT04739085` - Level of Agreement Between Clinical Defocus Curves and the Web-based Democritus Digital Acuity Reading Test wDDART
Not yet recruiting	`NCT05594537` - The Best Way to Improve the Near Visual Acuity After ZXR00 IOL Implantation
Completed	`NCT04242836` - Development and Validation of a Digital Optotype for Near Vision in Greek Language.
Completed	`NCT03457441` - Evaluation of Near Visual Acuity With ODYSIGHT, a Smartphone Based Medical App in Comparison to a Standardized Method	N/A
Completed	`NCT04907955` - Visual Performance Following Implantation of Presbyopia Correcting IOLs	N/A
Completed	`NCT05005624` - Validation of an Activities-of-daily-living Framework at Different Light Conditions
Completed	`NCT04059289` - Intermediate Vision in a Driving Simulator Environment: Comparison of the J&J EYHANCE With a Conventional Monofoc. IOL
Completed	`NCT05753189` - Phase 3 Safety Study for the Treatment of Presbyopia Subjects	Phase 3
Completed	`NCT04618224` - Development and Validation of an Internet-based Near and Intermediate-vision Reading Test
Completed	`NCT05656027` - Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia	Phase 3
Completed	`NCT05431543` - Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia	Phase 2
Completed	`NCT05728944` - Phase 3 Efficacy Study of LNZ101 for the Treatment of Presbyopia	Phase 3